Ocugen outlines 2026 BLA submission and expects three pivotal filings within three years amid leadership expansion
Source: SeekingAlpha
2026-03-04 13:33:06 ET
More on Ocugen
- Ocugen, Inc. (OCGN) Q4 2025 Earnings Call Transcript
- Ocugen: Why I Don't Read Too Much Into The Selloff On Phase 2 GA Data
- Ocugen, Inc. (OCGN) Discusses OCU410 Phase 2 ArMaDa Trial Data and Clinical Update for Geographic Atrophy Transcript
- Ocugen GAAP EPS of -$0.06 in-line
- Ocugen Q4 2025 Earnings Preview
Read the full article on Seeking Alpha
For further details see:
Ocugen outlines 2026 BLA submission and expects three pivotal filings within three years amid leadership expansion
Ocugen, Inc.
NASDAQ: OCGN
OCGN Trading
5.72% G/L:
$1.755 Last:
2,728,614 Volume:
$1.68 Open:
OCGN Latest News
March 04, 2026 08:15:00 am
Ocugen Provides Business Update with Fourth Quarter and Full Year 2025 Financial Results
OCGN Stock Data
$478,717,026
313,395,708
0.26%
38
N/A
Biotechnology & Life Sciences
Healthcare
US
Malvern
